We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Stem Cell Therapeutics Corp. Announces Top-Line Results for the Modified REGENESIS Phase IIb Stroke Trial

News   May 26, 2010

 
Stem Cell Therapeutics Corp. Announces Top-Line Results for the Modified REGENESIS Phase IIb Stroke Trial
 
 
Advertisement
 

RELATED ARTICLES

Study Indicates a Lack of Diversity in COVID-19 Clinical Trials

News

Despite disproportionately higher rates of COVID-19 infection, hospitalization and death among people of color, minority groups are significantly underrepresented in COVID-19 clinical trials, according to a new study.

READ MORE

Russia’s COVID-19 Vaccine “Approved" Despite No Phase III Data

News

The scientific community has been left somewhat perplexed today after Russian President Vladamir Putin announced that Russian authorities have approved the world's first COVID-19 vaccine.

READ MORE

Training Neural Circuits-in-a-Dish Early Makes for Sharper Responses

News

When it comes to training neural circuits for tissue engineering or biomedical applications, a new study suggests a key parameter: Train them young.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE